| Dec'13 | Dec'12 | Dec'11 | Dec'10 | |||
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES IN CONTINUING OPERATIONS: | ||||||
Net loss | ||||||
-3,417 | -3,362 | -1,119 | -9,796 | |||
Adjustments to reconcile net loss to net cash used in operating activities in continuing operations: | ||||||
Depreciation and amortization | ||||||
184 | 183 | - | 968 | |||
Depreciation expense | ||||||
- | - | 123 | - | |||
Share-based compensation | ||||||
664 | 1,879 | 1,109 | 2,461 | |||
Net gain on release of restricted assets and derecognition of liabilities of discontinued operations | ||||||
0 | 544 | - | - | |||
Gain on derecognition of legacy payables | ||||||
0 | 1,787 | - | - | |||
Loss on conversion of debt | ||||||
233 | 1,304 | - | - | |||
Net gain on release of restricted assets and derecognition of liabilities of discontinued operations | ||||||
- | - | 0 | - | |||
Gain on derecognition of legacy payables | ||||||
- | - | 0 | - | |||
Loss on conversion of debt | ||||||
- | - | 0 | - | |||
Change in fair value of derivative liabilities | ||||||
0 | 125 | 1,204 | 77 | |||
Gain on settlement of LTAS selling shareholder debt | ||||||
58 | 0 | - | - | |||
Fair value of modification of warrants | ||||||
- | - | - | -29 | |||
Impairment of intangible assets | ||||||
- | - | - | 1,210 | |||
Loan interest capitalized to debt | ||||||
432 | 420 | 419 | 419 | |||
Amortization of deferred financing costs | ||||||
20 | 18 | - | - | |||
Shares issued as inducement to loan | ||||||
34 | 0 | - | - | |||
Amortized deferred financing costs | ||||||
- | - | 0 | - | |||
Change in operating assets and liabilities: | ||||||
Gain on extinguishment of liabilities to joint venture partner | ||||||
- | - | 2,474 | 363 | |||
Accounts receivable | ||||||
-120 | 8 | 8 | - | |||
Accounts receivable from related party | ||||||
11 | 27 | - | - | |||
Accounts receivable from related party | ||||||
- | - | 0 | - | |||
Inventories | ||||||
-154 | -4 | -15 | -1,545 | |||
Prepaid expenses | ||||||
-8 | -56 | -36 | - | |||
Property and equipment | ||||||
- | - | 3 | - | |||
Deposits | ||||||
-50 | 50 | -0 | - | |||
Deposits | ||||||
- | - | 0 | - | |||
Accounts payable | ||||||
186 | 535 | 521 | 1,438 | |||
Accounts payable due related party | ||||||
-57 | 0 | - | - | |||
Other accrued liabilities | ||||||
1,100 | 804 | 639 | 136 | |||
Other accrued liabilities | ||||||
- | - | - | -21 | |||
Deferred revenues | ||||||
-5 | -197 | 204 | - | |||
NET CASH USED BY OPERATING ACTIVITIES IN CONTINUING OPERATIONS | ||||||
-359 | -896 | -1,736 | -1,684 | |||
INVESTING ACTIVITIES: | ||||||
Acquisition, net of cash acquired | ||||||
-158 | 0 | 336 | - | |||
Deposits | ||||||
- | - | - | 10 | |||
NET CASH PROVIDED BY INVESTING ACTIVITIES IN CONTINUING OPERATIONS | ||||||
158 | 0 | -339 | 10 | |||
FINANCING ACTIVITIES: | ||||||
Proceeds from notes payable | ||||||
150 | 0 | - | - | |||
Proceeds from sale of common stock | ||||||
120 | 0 | 2,051 | 1,703 | |||
Proceeds from debenture, net of deferred financing costs | ||||||
- | - | 0 | - | |||
Proceeds from convertible debt, net of deferred financing costs | ||||||
0 | 354 | 0 | - | |||
Proceeds from purchases under the Equity Investment Agreement | ||||||
0 | 585 | - | - | |||
NET CASH PROVIDED BY FINANCING ACTIVITIES IN CONTINUING OPERATIONS | ||||||
270 | 939 | 2,051 | 1,703 | |||
NET CHANGE IN CASH | ||||||
69 | 43 | -23 | - | |||
NET CHANGE IN CASH | ||||||
- | - | - | 29 | |||
SUPPLEMENTAL INFORMATION: | ||||||
Interest paid | ||||||
0 | 0 | 38 | 0 | |||
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | ||||||
Reclassification of long-term convertible notes payable to current notes payable | ||||||
267 | 0 | - | - | |||
Common stock issued for LTAS acquisition | ||||||
672 | 0 | - | - | |||
Common stock issued for settlement of LTAS selling shareholder debt | ||||||
192 | 0 | - | - | |||
Common stock issued in exchange for convertible debt | ||||||
76 | 1,692 | - | - | |||
Common stock issued as payments for services | ||||||
367 | 458 | - | - | |||
Common stock issued for accrued settlements | ||||||
339 | 269 | - | - | |||
Common stock issued as payments for accrued salaries and directors fees | ||||||
100 | 103 | - | - | |||
Fair value of vested options issued for accrued salary conversions | ||||||
524 | 0 | - | - | |||
LTAS acquisition payable | ||||||
- | - | 250 | - | |||